These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 15249740

  • 1. Inhibition of growth hormone secretion in mild primary hyperparathyroidism.
    Coiro V, Volpi R, Capretti L, Finardi L, Magotti MG, Manfredi G, Chiodera P, Saccani Jotti G.
    Horm Res; 2004; 62(2):88-91. PubMed ID: 15249740
    [Abstract] [Full Text] [Related]

  • 2. GH secretion is impaired in patients with primary hyperparathyroidism.
    Gasperi M, Cecconi E, Grasso L, Bartalena L, Centoni R, Aimaretti G, Broglio F, Miccoli P, Marcocci C, Ghigo E, Martino E.
    J Clin Endocrinol Metab; 2002 May; 87(5):1961-4. PubMed ID: 11994325
    [Abstract] [Full Text] [Related]

  • 3. Primary hyperparathyroidism is associated with marked impairment of GH response to acylated ghrelin.
    Cecconi E, Bogazzi F, Morselli LL, Gasperi M, Procopio M, Gramaglia E, Broglio F, Giovannetti C, Ghigo E, Martino E.
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):197-201. PubMed ID: 18221398
    [Abstract] [Full Text] [Related]

  • 4. The reduction of bone mineral density in postmenopausal women with primary hyperparathyroidism is higher in the presence of concomitant GH secretion impairment.
    Cecconi E, Gasperi M, Genovesi M, Bogazzi F, Grasso L, Cetani F, Procopio M, Marcocci C, Bartalena L, Martino E.
    Eur J Endocrinol; 2006 Jul; 155(1):41-5. PubMed ID: 16793948
    [Abstract] [Full Text] [Related]

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M, Bossoni S, Alí A, Doga M, Reimondo G, Milani G, Peretti P, Manelli F, Angeli A, Giustina A.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [Abstract] [Full Text] [Related]

  • 7. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.
    Alvarez-Castro P, Isidro ML, Garcia-Buela J, Leal-Cerro A, Broglio F, Tassone F, Ghigo E, Dieguez C, Casanueva FF, Cordido F.
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):250-5. PubMed ID: 15272922
    [Abstract] [Full Text] [Related]

  • 8. Immunoreactive growth hormone-releasing hormone (IR-GHRH) in the feto-placental circulation and differential effects of L-dopa, L-arginine and somatostatin-14 on the plasma levels of IR-GHRH in normal adults.
    Saito H, Hosoi E, Yamasaki R, Kameyama K, Irahara M, Ohno Y, Saito S.
    Horm Metab Res; 1997 Apr; 29(4):184-9. PubMed ID: 9178029
    [Abstract] [Full Text] [Related]

  • 9. Cranially irradiated adult cancer survivors may have normal spontaneous GH secretion in the presence of discordant peak GH responses to stimulation tests (compensated GH deficiency).
    Darzy KH, Thorner MO, Shalet SM.
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):287-93. PubMed ID: 18673465
    [Abstract] [Full Text] [Related]

  • 10. Growth hormone secretion in primary and secondary hyperparathyroidism.
    Cecconi E, Gasperi M, Genovesi M, Bogazzi F, Grasso L, Procopio M, Marcocci C, Pinchera A, Bartalena L, Martino E.
    J Endocrinol Invest; 2005 Feb; 28(2):113-6. PubMed ID: 15887855
    [Abstract] [Full Text] [Related]

  • 11. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
    Procopio M, Maccario M, Savio P, Valetto MR, Aimaretti G, Grottoli S, Oleandri SE, Baffoni C, Tassone F, Arvat E, Camanni F, Ghigo E.
    Panminerva Med; 1998 Mar; 40(1):13-7. PubMed ID: 9573747
    [Abstract] [Full Text] [Related]

  • 12. Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa.
    Gianotti L, Arvat E, Valetto MR, Ramunni J, Di Vito L, Maccagno B, Camanni F, Ghigo E.
    Biol Psychiatry; 1998 Feb 01; 43(3):181-7. PubMed ID: 9494699
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone secretion among HIV infected patients: effects of gender, race and fat distribution.
    Koutkia P, Eaton K, You SM, Breu J, Grinspoon S.
    AIDS; 2006 Apr 04; 20(6):855-62. PubMed ID: 16549969
    [Abstract] [Full Text] [Related]

  • 14. Repeated administration of growth hormone-releasing hormone with or without previous administration of pyridostigmine in insulin-dependent diabetes mellitus.
    Martina V, Bruno G, Tagliabue M, Maccario M, Bertaina S, Zumpano E, Arvat E, Ghigo E, Camanni F.
    Horm Metab Res; 1997 Apr 04; 29(4):180-3. PubMed ID: 9178028
    [Abstract] [Full Text] [Related]

  • 15. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F, Ahmad AM, Ul-Haq M, Durham BH, Whittingham P, Fraser WD, Vora JP.
    J Bone Miner Res; 2008 May 04; 23(5):721-9. PubMed ID: 18052753
    [Abstract] [Full Text] [Related]

  • 16. Improvement of growth hormone deficiency in patients with primary hyperparathyroidism after parathyroidectomy: results of a prospective study.
    Cecconi E, Gasperi M, Bogazzi F, Grasso L, Genovesi M, Marcocci C, Pinchera A, Procopio M, Bartalena L, Martino E.
    J Clin Endocrinol Metab; 2004 Mar 04; 89(3):1213-6. PubMed ID: 15001612
    [Abstract] [Full Text] [Related]

  • 17. The dependency of calcium set point on basal plasma calcium in dialysis patients: a better explanation for the discrepancies regarding its link with PTH secretion than methodological differences.
    Hardy-Yverneau P, Shenouda M, Moriniere P, Legallais C, Brazier M, Achard J, Fournier A.
    Clin Nephrol; 1998 Oct 04; 50(4):236-46. PubMed ID: 9799069
    [Abstract] [Full Text] [Related]

  • 18. Impaired GH secretion to provocative stimuli in two families with hypocalciuric hypercalcaemia.
    Cecconi E, Bogazzi F, Cetani F, Grasso L, Marcocci C, Genovesi M, Procopio M, Gasperi M, Pinchera A, Ghigo E, Martino E.
    Clin Endocrinol (Oxf); 2003 Nov 04; 59(5):604-6. PubMed ID: 14616884
    [Abstract] [Full Text] [Related]

  • 19. Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism.
    Ramirez JA, Goodman WG, Gornbein J, Menezes C, Moulton L, Segre GV, Salusky IB.
    J Clin Endocrinol Metab; 1993 Jun 04; 76(6):1489-94. PubMed ID: 8501155
    [Abstract] [Full Text] [Related]

  • 20. Primary hyperparathyroidism is associated with an impaired secretion of growth hormone but not of the other anterior pituitary hormones.
    Cecconi E, Gasperi M, Grasso L, Genovesi M, Aimaretti G, Broglio F, Bartalena L, Marcocci C, Martino E.
    J Endocrinol Invest; 2002 Mar 04; 25(3):RC7-9. PubMed ID: 11936476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.